The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Morano, Jamie P ^a   Gibson, Britton A ^a   Altice, Frederick L ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL PRACTICE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DOMESTIC VIOLENCE; ETHNIC GROUP; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH INSURANCE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HETEROSEXUAL MALE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIXED INFECTION; PROPHYLAXIS; SYPHILIS; UNITED STATES; URBAN AREA; VIRUS TRANSMISSION;

ADULT; CITIES; COINFECTION; EPIDEMICS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW ENGLAND;

EID: 84877726790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064321     Document Type: Article

References (45)

1. Armstrong G, Wasley A, Simard E, McQuillan G, Kuhnert W, Alter M, (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Int Med 144: 705-714.
2. Centers for Disease Control and Prevention (2011) HIV and Viral Hepatitis Fact Sheet. Available: http://www.cdc.gov/hiv/resources/factsheets/hepatitis.htm. Accessed 2012 May 31.
3. Spradling P, Richardson J, Buchacz K, Moorman A, Finelli L, Bell B, et al. (2010) Trends in hepatitis C virus infection among patients in the HIV outpatient study, 1996-2007. J Acquir Immune Defic Syndr 53: 388-896.
4. Weber R, Sabin C, Friis-Møller N, Reiss P, El-Sadr WM, et al. (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med 166: 1632-1641.
5. Ly K, Xing J, Klevens R, Jiles R, Ward J, Holmberg S, (2012) The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Int Med 156: 271-278.
6. Sulkowski M, Benhamou Y, (2007) Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat 14: 371-386.
7. Lacombe K, Rockstroh J, (2012) HIV and viral hepatitis coinfections: advances and challenges. Gut 61Suppl 1: i47-58.
8. Hermanstyne K, Bangsberg D, Hennessey K, Cindy Weinbaum C, Hahn J (March 26, 2012) The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Pub Health 34: 330-339.
9. Springer SA, Chen S, Altice FL, (2010) Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health 87: 592-602.
10. Nuttbrock L, Rosenblum A, Magura S, McQuistion H, Joseph H, (2000) The association between cocaine use and HIV/STDs among soup kitchen attendees in New York City. J Acquir Immune Defic Syndr 25: 86-91.
11. Russell M, Chen M, Nochajski T, Testa M, Zimmerman S, Hughes P, (2009) Risky sexual behavior, bleeding caused by intimate partner violence, and Hepatitis C virus infection in patients of a sexually transmitted disease clinic. Am J Public Health 99: S173-S179.
12. Rosen DL, Schoenbach VJ, Wohl DA, White BL, Stewart PW, Golin CE, (2009) An evaluation of HIV testing among inmates in the North Carolina prison system. Am J Public Health 99Suppl 2: S452-459.
13. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH, (2010) Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376: 59-79.
14. US Census, US Department of Commerce (2010) State and county quick facts: New Haven, CT. Available: http://quickfacts.census.gov/qfd/states/09/0952000.html. Accessed 2012 August 14.
15. Heimer R, Kaplan E, O'Keefe E, Khoshnood K, Altice F, (1994) Three years of needle exchange in New Haven: What have we learned? AIDS Public Policy J 9: 59-74.
16. Altice F, Maru D, Bruce R, Springer S, Friedland G, (2007) Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis 45: 770-778.
17. Altice F, Bruce R, Walton M, Buitrago M, (2005) Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health 82: 151-161.
18. Altice F, Mezger J, Hodges J, Bruce R, Marinovich A, Walton M, et al. (2004) Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis 38: S376-387.
19. Pollack H, Khoshnood K, Blankenship K, Altice F, (2002) The impact of needle exchange-based health care services on emergency department use. J Gen Intern Med 17: 341-348.
20. Liebman J, Lamberti P, Altice F, (2002) Effectiveness of a mobile medical van in providing screening services for STDs and HIV. Public Health Nurs 19: 345-353.
21. Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, et al. (2011) Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr 56Suppl 1: S68-75.
22. Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. (2011) HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr 56Suppl 1: S22-32.
23. Sullivan LE, Bruce RD, Altice FL, Haltiwanger D, Lucas GM, Eldred L, et al. (2006) Initial strategies for integrating buprenorphine into HIV care settings in the United States. Clin Infect Dis 43Suppl 4: S191-196.
24. Schwarz RK, Bruce RD, Ball SA, Herme M, Altice FL, (2009) Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening. Am J Drug Alcohol Abuse 35: 439-444.
25. Maru D, Bruce R, Walton M, Springer S, Altice F, (2009) Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr 50: 176-181.
26. Maru D, Bruce R, Walton M, Springer S, Altice F, (2008) Initiation, adherence, and retention in a randomized in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav 12: 284-294.
27. Smith-Rohrberg D, Mezger J, Walton M, Bruce RD, Altice FL, (2006) Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr 43Suppl 1: S48-53.
28. Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL, (2012) Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials 33: 436-444.
29. U.S. Census Bureau (2012) Selected Social Characteristics In the United States, 2007-2011: American community survey 5-year estimates, New Haven City, CT. U.S. Census Bureau.
30. Connecticut Department of Public Health (2012) New Haven people living with HIV infection by risk, sex, age group, 1981-2011. Hartford, CT. Available: http://www.ct.gov/dph/lib/dph/aids_and_chronic/surveillance/city_and_county/city_new_haven_plwhivaids_table.pdf. Accessed 2013 March 5.
31. CT Department of Public Health (2010) Epidemiologic profile of HIV/AIDS [and Hepatitis C] in Connecticut: Prevalence of HIV/AIDS [and Hepatitis C], Connecticut, 2010. Hartford, CT.
32. McLennan A, Kushner H, Metzger D, et al. (1992) The fifth edition of the addiction severity index. J Subst Abuse Treat 9: 199-213.
33. Dunn O, (1964) Multiple Comparisons Using Rank Sums. Technometrics 6: 241-252.
34. Baum C, (2006) Stata tip 38: Testing for groupwise heteroskedasticity. The Stata Journal 6: 590-592.
35. Meyer J, Springer S, Altice F, (2011) Substance abuse, violence, and HIV in women: a literature review of the syndemic. Journal of Women's Health (Larchmt) 20: 991-1006.
36. Leichliter J, Haderxhanaj L, Chesson H, Aral S, for the Division of STD Prevention Centers for Disease Control and Prevention (2013) Temporal trends in sexual behavior among men who have sex with men in the United States, 2002 to 2006-2010. J Acquir Immune Defic Syndr, Ahead of Print.
37. Bradshaw D, Matthews G, Mark Danta M, (2013) Sexually transmitted hepatitis C infection: the new epidemic in MSM? Curr Opin Infect Dis 26: 66-72.
38. Matser A, Vanhommerig J, Schim van der Loeff M, Geskus R, de Vries H, al e, (2013) HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for Hepatitis C infection. PLoS One 8: e57740.
39. Altice F, Kamarulzaman A, Soriano V, Schechter M, Friedland G, (2010) Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376: 367-387.
40. American Public Health Association (2012) Why do we need the Affordable Care Act. Available: http://www.apha.org/advocacy/HealthReform/ACAbasics. Accessed 2012 August 20.
41. U.S. Department of Health and Human Services (2012) How the Affordable Care Act Helps People Living with HIV/AIDS: 2011 and Beyond. Available: http://www.healthcare.gov/news/factsheets/2010/09/affordable-care-act-people-hiv-aids.html. Accessed 2012 August 27.
42. National Alliance of State and Territorial AIDS Directors (2012) ADAP Watch. Available: http://www.nastad.org/Docs/122858_NASTAD ADAP Watch -8.17.12.pdf. Accessed 2012 August 17.
43. Siskin A (March 22, 2011) Treatment of noncitizens under the patient protection and Affordable Care Act. Congressional Research Service, Washington, DC.
44. Mermin J, Fenton KA, (2012) The future of HIV prevention in the United States. JAMA 308: 347-348.
45. MacNeil J, Pauly B, (2011) Needle exchange as a safe haven in an unsafe world. Drug Alcohol Review 30: 25-32.